Advertisement
Hope on the Horizon: Ushering in the New Era in the Management of Vitiligo
Global Vitiligo Foundation President Seemal Desai, MD, Associate Professor of Clinical Dermatology at the University of Texas-Southwestern in Dallas, TX, and Pearl E. Grimes, MD, Director of the Vitiligo and Pigmentation Institute of Southern California in Los Angeles, CA, have devoted much of their careers to treating vitiligo. They discuss the revolution and evolution of vitiligo treatment, which was spurred by the approval of topical ruxolitinib (Opzelura, Incyte) and is bolstered by a robust pipeline.
Advertisement
About This Educational Video Series
This educational video series provides expert commentary on the current treatment landscape for patients with vitiligo.